REED

Reed's is a structurally unprofitable micro-cap in slow-motion decline. Revenue has fallen every year from $53.0M (FY2022) to $34.1M (FY2025), a -10.2% YoY drop in the latest year, while the company has posted net losses in each of the last five years totaling well over $80M. FY2025 alone booked a -$15.8M net loss on a -44.5% operating margin, and gross margin collapsed to 20.4% (gross profit down -38.8% YoY). Return on equity is -173%, and accumulated deficit stands at -$168M against just $9.15M of equity — this is a business that has never demonstrated it can fund itself from operations.

The balance sheet is the acute problem. Operating cash flow was -$17.0M in FY2025 (a -178% swing), yet reported cash is a razor-thin $713K (note: this figure is XBRL-tagged to FY2011 and thus unreliable, which only deepens the uncertainty). The MD&A confirms the company 'continued to finance our operations through... public and private issuance of common stock' and warns 'there can be no assurance that such financing will be available to us on favorable terms or at all.' Shares outstanding fell 73.9% YoY — consistent with a reverse split — and a December 4, 2025 underwritten public offering signals ongoing, dilutive capital-raising. Owners face a real risk of being repeatedly diluted just to keep the lights on.